Rising Pharma Holding, Inc. is recalling 2,064 bottles of Carbidopa, Levodopa, and Entacapone tablets (25 mg/100 mg/200 mg) because some bottles may actually contain a higher strength version of the medication (37.5 mg/150 mg/200 mg). The recall was initiated after a complaint that a sealed bottle of the lower strength medication contained the higher strength film-coated tablets. These medications are used to treat Parkinson's disease, and taking a higher dose than prescribed could lead to serious health complications. Consumers should contact their healthcare provider or pharmacist immediately to discuss their medication.
Patients may inadvertently take a higher dose of Carbidopa, Levodopa, and Entacapone than prescribed, which can lead to increased side effects or toxicity associated with these medications.
You have 2 options:
Recall #: D-0029-2026. Manufactured by Suven Pharmaceuticals Limited in India for Rising Pharma Holdings, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.